1. Introduction {#sec1-ijms-20-05737}
===============

1.1. Glycerol in Industrial Biotechnology {#sec1dot1-ijms-20-05737}
-----------------------------------------

Glycerol (propane-1,2,3-triol) is a constituent of triglycerides, typically produced from fat splitting or transesterification during soap or biodiesel production. Diverse applications of glycerol in cosmetics, toiletries, pharmaceuticals, food, and beverages have maintained a constant demand for this commodity chemical. Uncharacteristically, the supply of glycerol is currently dictated not by its own demand, but rather by the demand of biodiesel. A typical biodiesel plant generates 10% (w/w) of glycerol by-product per unit of biodiesel produced \[[@B1-ijms-20-05737]\]. The increasing global demand and production of biodiesel have created a surplus of crude glycerol, thereby driving the glycerol price down. While there is little incentive to purify this crude glycerol given its low price and high water content, disposal of the crude glycerol presents both environmental and economic challenges due to the impurities present. This oversupply of crude glycerol has spurred the exploration of glycerol utilization to increase the value chain of biodiesel production. Potential applications include fermentation to high-value chemicals, digestion to produce biogas, and pyrolysis and liquefaction for bio-oil production \[[@B2-ijms-20-05737],[@B3-ijms-20-05737]\].

Microbial fermentation of glycerol into high-value chemicals such as 1,3-propanediol, alcohols, short-chain organic acids, polyhydroxyalkanoates, and hydrogen is a very promising application of crude glycerol \[[@B3-ijms-20-05737]\]. The productivity of various microorganisms using crude glycerol as feedstock has been comprehensively reviewed \[[@B4-ijms-20-05737]\]. While natural pathways for glycerol metabolism exist in many microorganisms, some are unsuitable for industrial applications due to their potential pathogenicity, like *Enterococcus faecalis* \[[@B5-ijms-20-05737]\], *Listeria monocytogenes* \[[@B6-ijms-20-05737]\], and *Mycoplasma* spp. \[[@B7-ijms-20-05737]\]. Other requirements, such as the availability of genetic engineering tools to introduce and tune metabolic pathways, further reduce the number of useful microorganisms for industrial glycerol biotransformation.

1.2. *Cupriavidus necator* H16 Can Produce Polyhydroxyalkanoate from Glycerol {#sec1dot2-ijms-20-05737}
-----------------------------------------------------------------------------

A promising candidate for glycerol biotransformation is the non-pathogenic Gram-negative bacterium *Cupriavidus necator* H16. Best known for its natural ability to accumulate polyhydroxybutyrate (PHB) \[[@B8-ijms-20-05737]\], recent literature has evidenced a rapid expansion of *C. necator* H16 applications \[[@B9-ijms-20-05737]\] and the development of its genetic engineering tools \[[@B10-ijms-20-05737]\]. While *C. necator* H16 can naturally metabolize glycerol, carbohydrates, lignin derivatives, organic acids, and even carbon dioxide \[[@B11-ijms-20-05737]\], its growth in glycerol is slow compared to favorable carbon sources like gluconate and fructose. Herein, we applied adaptive evolution to improve the glycerol assimilation in *C. necator* H16 leading to a variant that enables co-utilization of glycerol and gluconate. The isolated variant has a specific growth rate in glycerol that is 9.5 times faster than the wild-type. It utilizes gluconate and glycerol simultaneously, while the wild-type uses them sequentially. It also accumulates more PHB in glycerol medium than in gluconate medium, while the inverse is true for the wild-type strain. Genome sequencing and expression studies identified glycerol kinase as the key enzyme for improved glycerol utilization. Enhanced glycerol assimilation in the v6C6 variant was also extended to crude glycerol (sweetwater) from an industrial fat splitting process.

2. Results and Discussion {#sec2-ijms-20-05737}
=========================

2.1. Glycerol Metabolism in *C. necator* H16 Wild-Type {#sec2dot1-ijms-20-05737}
------------------------------------------------------

The growth of *C. necator* H16 at different glycerol concentrations (0.50%, 1.00%, and 2.00% (*w*/*v*)) were determined and compared to sodium gluconate (0.59% (*w*/*v*)), a preferred carbon source. The concentrations of 0.50% (*w*/*v*) glycerol and 0.59% (*w*/*v*) sodium gluconate were deliberately chosen to maintain the same carbon molarity (0.16 M) and *C. necator* H16 showed similar final optical densities (OD~600~) of 6.0 to 7.0 in both carbon sources at this carbon concentration. As shown in [Figure 1](#ijms-20-05737-f001){ref-type="fig"}, the growth in glycerol was slower than that in sodium gluconate. Growth in glycerol was characterized by a long lag phase of 110 h to reach the OD~600~ of 1.0, and a further 70 h before it achieved OD~600~ of 5.0 (late-exponential phase). This slow growth in glycerol required 180 h (i.e., 7.5 days) and is 12-times longer compared to the 15 h required by *C. necator* H16 to reach the same OD~600~ 5.0 in gluconate ([Figure 1](#ijms-20-05737-f001){ref-type="fig"} inset). Lag phase is the most poorly understood growth phase, lacking data that support the underlying physiological and molecular processes \[[@B12-ijms-20-05737]\]. In this case, one could only assume that the long lag phase is required for the bacterial cells to adapt and grow in the new environmental conditions. As shown in [Table 1](#ijms-20-05737-t001){ref-type="table"}, specific growth rate of *C. necator* H16 in 0.50% (*w*/*v*) glycerol was 0.021 h^−1^, much slower compared to 0.59% (*w*/*v*) sodium gluconate (0.24 h^−1^). The specific growth rates ([Table 1](#ijms-20-05737-t001){ref-type="table"}) in the different glycerol concentrations investigated were similar (0.020 h^−1^ to 0.026 h^−1^). Unsurprisingly, the maximal achievable OD~600~ values showed a positive correlation with the glycerol concentrations used (6.0 for 0.50%, 13.4 for 1.00%, and 19.9 for 2.00% (*w*/*v*)). The tested range of glycerol concentrations was not reported to be inhibitory for other microorganisms \[[@B13-ijms-20-05737],[@B14-ijms-20-05737],[@B15-ijms-20-05737]\] and increasing the concentration from 0.50% *(w*/*v*) to 2.00% (*w*/*v*) did not show growth inhibition of *C. necator* H16, suggesting the slow growth is likely attributed to slow glycerol metabolism.

2.2. Improved Glycerol Utilization in *C. necator* H16 by Adaptive Evolution {#sec2dot2-ijms-20-05737}
----------------------------------------------------------------------------

Factors limiting microbial growth in glycerol can include the lack of glycerol assimilation pathway \[[@B16-ijms-20-05737]\], lack of gene expression \[[@B17-ijms-20-05737]\] and metabolic pathway regulation \[[@B18-ijms-20-05737]\]. Since the underlying reason of slow *C. necator* H16 growth in glycerol is not understood, adaptive evolution was used to improve the specific growth rate of *C. necator* H16 in glycerol. Adaptive evolution exploits the linkage between carbon (glycerol) utilization and bacterial survival (growth), and was previously applied to different bacteria \[[@B19-ijms-20-05737],[@B20-ijms-20-05737]\].

Mineral salts medium (MSM) \[[@B21-ijms-20-05737]\] with 0.50% (*w*/*v*) glycerol as sole carbon source was used as the initial selective condition in adaptive evolution. The cell population adapted quickly over six serial passages with five to seven generations per cultivation round (Round 1 to Round 6; [Figure 2](#ijms-20-05737-f002){ref-type="fig"}a). Significant improvement in glycerol utilization was obtained, with the time taken to reach maximum optical density decreasing from nine days (Round 1) to four days (Round 2) and to two days (Round 3). The time required to reach maximum optical density did not improve from Round 3 to Round 6, but the lag phase in these rounds was shorter. This metabolic malleability of *C. necator* H16 was also previously demonstrated by its quick adaptation to glucose utilization \[[@B22-ijms-20-05737]\].

From the cell populations in Round 4 to Round 6, 83 single colonies from each round were screened in 96-well microtiter plates. From these, 39 improved variants were rescreened, before the best three variants with similar growth rate were identified as v6C6, v6G7, and v6F8 from Round 6. To ensure the improved phenotype is not a transient adaptation due to variation in gene expression pattern, these three variants were subjected to five consecutive rounds of cultivation in either synthetic medium (MSM with 1% (*w*/*v*) sodium gluconate) or complex medium (NB) in the absence of glycerol. When transferred back to MSM with 0.5% (*w*/*v*) glycerol, these three variants maintained their growth rates at the level when they were first isolated. This showed the improved growth rate in glycerol was a result of genetic modification and not simply a reversible physiological adaptation. Specific growth rate of v6C6 in glycerol was 0.20 h^−1^, 9.5 times the rate of wild-type strain in glycerol, and 83% the rate in sodium gluconate ([Table 1](#ijms-20-05737-t001){ref-type="table"}). The lag-phase of v6C6 cultivation in 0.50% (*w*/*v*) glycerol remained prominent, taking 17 h to reach OD~600~ of 1.0 and an additional 9 h to reach OD~600~ of 5.0 (late exponential phase) as shown in [Figure 2](#ijms-20-05737-f002){ref-type="fig"}b. This growth rate remained the same, whether the pre-culture was prepared in MSM with 1.00% (*w*/*v*) sodium gluconate or 0.50% (*w*/*v*) glycerol. Further adaptive evolution was performed on v6C6 using 0.25% (*w*/*v*), 2.00% (*w*/*v*) and 5.00% (*w*/*v*) glycerol in MSM followed by screening 267 variants, but it did not yield further improvement (data not shown).

2.3. *C. necator* H16 Variant v6C6 Co-Utilizes Glycerol and Gluconate {#sec2dot3-ijms-20-05737}
---------------------------------------------------------------------

The co-utilization of gluconate and glycerol by *C. necator* H16 wild-type and variant v6C6 was monitored using HPLC ([Figure 3](#ijms-20-05737-f003){ref-type="fig"}). When cultivated in mixed gluconate--glycerol carbon sources, *C. necator* H16 wild-type uses gluconate and glycerol sequentially ([Figure 3](#ijms-20-05737-f003){ref-type="fig"}b) while variant v6C6 co-utilizes gluconate and glycerol ([Figure 3](#ijms-20-05737-f003){ref-type="fig"}c). Co-utilization enabled v6C6 to achieve a higher optical density in mixed gluconate--glycerol (OD~600~ = 8.2) compared to either gluconate (OD~600~ = 5.97) or glycerol (OD~600~ = 7.7) alone ([Figure 3](#ijms-20-05737-f003){ref-type="fig"}a). Shown in [Figure 3](#ijms-20-05737-f003){ref-type="fig"}b for *C. necator* H16 wild-type, gluconate was completely utilized by 14.5 h and the OD~600~ subsequently increased from OD~600~ = 3.88 (14.5 h) to OD~600~ = 5.70 (74.5 h) through the utilization of glycerol. This contrasted with the OD~600~ \< 0.5 after 94.5 h when wild-type was cultivated using only glycerol. It is interesting that the use of gluconate as a co-substrate improved glycerol assimilation, though the preferred gluconate was assimilated first. This observation showed that mixed substrates can be used to enhance glycerol utilization, but it also highlighted the complexity of the regulation mechanism in carbon metabolism. Advantages of using co-substrates with glycerol during fermentation have previously been reported for other organisms. For instance, co-utilization of glycerol and monosaccharides in fermentation of *Clostridium diolis* can increase cell growth and 1,3-propanediol product formation \[[@B23-ijms-20-05737]\]. Similar observations were made for the production of fumaric acid with fungi *Rhizopus oryzae* \[[@B24-ijms-20-05737]\]. These observed improvements had been attributed to various reasons, including the protective role of glycerol under stress conditions \[[@B24-ijms-20-05737]\] and a higher ratio of intracellular NADH/NAD^+^ in co-utilization of glycerol and sugar \[[@B23-ijms-20-05737]\].

2.4. Variant v6C6 Has Decreased N-acetylglucosamine and Fructose Utilization {#sec2dot4-ijms-20-05737}
----------------------------------------------------------------------------

*N*-acetylglucosamine, fructose, gluconate, and glycerol are catabolized in the Entner--Doudoroff (ED) pathway to yield pyruvate in *C. necator* H16 ([Figure 4](#ijms-20-05737-f004){ref-type="fig"}a). The utilization of the different carbon sources within the ED pathway by v6C6 was investigated in 1.0% (*w*/*v*) of each of these carbon sources as well as in mixed sodium gluconate--glycerol (0.5% (*w*/*v*) each). Excluding the samples with glycerol, both wild-type and v6C6 grew fastest in gluconate, followed by fructose, and finally *N*-acetylglucosamine ([Figure 4](#ijms-20-05737-f004){ref-type="fig"}b--d). While the growth rate of variant v6C6 (0.14 ± 0.01 h^−1^) is similar to wild-type (0.13 ± 0.01 h^−1^) in 1.0% (*w*/*v*) sodium gluconate, its growth in fructose and *N*-acetylglucosamine is significantly slower ([Figure 4](#ijms-20-05737-f004){ref-type="fig"}b--d). In fructose, the wild-type reached stationary phase by 64 h while v6C6 was still in its lag phase ([Figure 4](#ijms-20-05737-f004){ref-type="fig"}c). The same phenomenon was observed for *N*-acetylglucosamine ([Figure 4](#ijms-20-05737-f004){ref-type="fig"}d), where v6C6 was in its lag phase when the wild-type reached stationary phase at 136 h. In media with glycerol, variant v6C6 grew faster than the wild-type ([Figure 4](#ijms-20-05737-f004){ref-type="fig"}e,f), as observed in [Figure 3](#ijms-20-05737-f003){ref-type="fig"} despite the differences in cultivation conditions (pre-culture prepared in nutrient broth instead of MSM with 1% (*w*/*v*) sodium gluconate, lower starting OD~600~ at 0.04 instead of 0.1, higher concentrations of gluconate and glycerol).

Since mutations occur randomly during adaptive evolution, the cause of significantly slower growth in *N*-acetylglucosamine and fructose is unclear. It was previously shown that the insertion of *glpK~Ec~* to the *C. necator* H16 chromosome improved its glycerol utilization without affecting its growth on fructose \[[@B25-ijms-20-05737]\]. It is thus unlikely that the mutated GlpK in v6C6 is the cause of decreased fructose assimilation. We can only assume that proteins/reactions involved directly or indirectly in the metabolic pathway between *N*-acetylglucosamine-6-phosphate to gluconate-6-phosphate were affected ([Figure 4](#ijms-20-05737-f004){ref-type="fig"}a). Poor assimilation of *N*-acetylglucosamine and fructose can also be due to poorer substrate transport into the cell. However, *C. necator* H16 uses different transport systems for the two substrates; *N*-acetylglucosamine enters the cell via a porin (NagC) in the outer membrane \[[@B26-ijms-20-05737]\] and fructose uptake is mediated by an ABC-type transporter \[[@B8-ijms-20-05737]\].

2.5. Variant v6C6 Produced More PHB from Glycerol {#sec2dot5-ijms-20-05737}
-------------------------------------------------

PHB productivity of the wild-type and v6C6 in both gluconate and glycerol were surveyed using the Nile red assay \[[@B27-ijms-20-05737]\], a lipophilic stain widely used for PHB quantification ([Figure S1](#app1-ijms-20-05737){ref-type="app"}). For both strains and in both carbon sources, higher fluorescence was obtained in nitrogen-limiting media ([Figure 5](#ijms-20-05737-f005){ref-type="fig"}), in agreement with the known fact that *C. necator* H16 produces more PHB under nutrient stress \[[@B28-ijms-20-05737]\]. Results also showed that, under nitrogen-limiting conditions, *C. necator* H16 wild-type produced more PHB in gluconate than in glycerol across all growth phases. Interestingly, the reverse is true for the v6C6 variant, where more PHB was produced from glycerol. Maximum PHB production from glycerol was achieved at the early stationary phase in nitrogen-limiting medium for v6C6, and it is 19% more than the PHB produced in the wild-type strain. We further confirmed PHB production through Nile red staining of PHB granules and visualization using fluorescence microscopy ([Figure S2](#app1-ijms-20-05737){ref-type="app"}).

2.6. Variant v6C6 Showed Superior Growth in Crude Glycerol {#sec2dot6-ijms-20-05737}
----------------------------------------------------------

All aforementioned experiments were conducted using laboratory-grade glycerol with purity over 99%. To verify the potential of the v6C6 variant for industrial application, we conducted comparative growth studies using crude glycerol (commonly known as sweetwater) obtained from a high-pressure fat-splitting process ([Figure 6](#ijms-20-05737-f006){ref-type="fig"}). Though composed of mainly water and glycerol, crude glycerol is a complex mixture that contains impurities such as free fatty acid, unreacted mono-, di-, and tri-glycerides, inorganic salts, and a variety of matter organic non-glycerol (MONG). At all crude glycerol concentrations tested (4% (*v*/*v*), 2% (*v*/*v*), and 1% (*v*/*v*)), v6C6 showed higher specific growth rates and shorter lag phase compared to wild-type ([Figure 6](#ijms-20-05737-f006){ref-type="fig"}a), matching the growth profile observed in laboratory-grade glycerol ([Figure 6](#ijms-20-05737-f006){ref-type="fig"}b). Specific growth rate of v6C6 in 1% to 4% (*v*/*v*) crude glycerol ([Table 2](#ijms-20-05737-t002){ref-type="table"}) is 0.17 h^−1^ to 0.22 h^−1^, similar to the specific growth rate in 0.5% (*w*/*v*) pure glycerol (0.20 h^-1^).

2.7. Genome Sequencing of Improved Glycerol Variants {#sec2dot7-ijms-20-05737}
----------------------------------------------------

The genomes of variants v6C6, v6G7, and v6F8 and wild-type were sequenced to identify the number, location, and nature of their genetic modification(s). *C. necator* H16 has two chromosomes and one megaplasmid, with a genome size of 7,416,678 bp. All genomes sequenced have more than 30× mean coverage. Based on the variant calling results of the sequenced genome, a list of four non-synonymous mutations, one insertion, and one deletion were identified against the wild-type genome ([Table 3](#ijms-20-05737-t003){ref-type="table"}). These four mutations resulted in amino acid changes in the four proteins encoded at the gene loci H16_A0689, H16_A1373, H16_A2507, and H16_A3075 ([Table 3](#ijms-20-05737-t003){ref-type="table"}). With the exception of H16_A1373, the other mutations are found in all three variants.

Based on the genome annotation (accession number NC_008313, NC_008314, and NC_005241 for chromosome 1, chromosome 2, and megaplasmid pHG1, respectively), the gene encoded by H16_A2507 is predicted to be a glycerol kinase (GlpK) by protein homology. Glycerol kinase is known to participate in the glycerol metabolism by phosphorylating glycerol to glycerol-3-phosphate ([Figure 4](#ijms-20-05737-f004){ref-type="fig"}a). Gene locus H16_A0689 encodes an ornithine cyclodeaminase, an enzyme that directly converts ornithine to proline. H16_A1373 is predicted to be a PAS domain-containing sensor histidine kinase and H16_A3075 encodes a dihydropyrimidinase, a hydrolase that catalyzes the ring-opening of 5,6-dihydrouracil to form 3-ureidopropanoate. It is unclear how these three proteins encoded by H16_0689, H16_1373, and H16_3075 can impact *C. necator* H16 glycerol metabolism or if they have any effect at all.

As a further verification of the mutation in *glpK~v6C6~* gene (gene locus H16_A2507) in v6C6, the gene including its 500-bp upstream element were amplified by PCR and sent for sequencing. Sanger sequencing result of the PCR fragment verified the W480S mutation identified in genome sequencing and no mutations were found in the upstream element where its promoter possibly resides. Being present in all three variants (v6C6, v6G7, and v6F8) suggests the enrichment of W480S mutation during cultivation as it conferred superior growth in glycerol. A conserved domain search \[[@B29-ijms-20-05737]\] revealed that W480 is fairly conserved in a multiple sequence alignment of GlpK~H16~ against related proteins spanning a variety of organisms ([Figure S3](#app1-ijms-20-05737){ref-type="app"}). Based on the GlpK~H16~ protein model created using GlpK~Ec~ (PDB 1BOT) as a template ([Figure S4](#app1-ijms-20-05737){ref-type="app"}), W480 resides on a coiled region, away from the catalytic center. As W480 is not on any known activation loop or glycerol-binding and ATP-binding site in GlpK \[[@B30-ijms-20-05737],[@B31-ijms-20-05737]\], it is difficult to predict how or if the mutation resulted in alteration of its catalytic function. Other possibilities are the mutation leads to better expression due to codon change, better/faster protein folding, or better protein solubility within the cellular environment.

To gain further insights of the four non-synonymous mutations identified in genome sequencing, the four genes were amplified from v6C6 and cloned for constitutive expression in a P*~j5~*-based constitutive plasmids ([Figure 7](#ijms-20-05737-f007){ref-type="fig"}a, [Table S1](#app1-ijms-20-05737){ref-type="app"}) \[[@B10-ijms-20-05737]\]. The constructs were transformed into *C. necator* wild-type and cultivated in MSM with 1.0% (*w*/*v*) glycerol. Constitutive expression of GlpK~v6C6~ encoded by *glpK~v6C6~* in v6C6 improved growth in MSM with 1.0% (*w*/*v*) glycerol ([Figure S5](#app1-ijms-20-05737){ref-type="app"}). No difference was, however, observed when the other three protein variants were expressed in the *C. necator* H16 wild-type strain ([Figure S5](#app1-ijms-20-05737){ref-type="app"}). It is thus likely that GlpK contributed to the improved glycerol assimilation in v6C6. However, expressing GlpK~v6C6~ alone in *C. necator* H16 was not sufficient to reproduce the phenotype of v6C6 ([Table 1](#ijms-20-05737-t001){ref-type="table"}), suggesting potential synergistic effect of the mutations found in v6C6 variant. It is worth mentioning that expression of *Escherichia coli* GlpK (GlpK~Ec~) in *C. necator* H16 was previously noted to improved glycerol assimilation \[[@B25-ijms-20-05737]\].

2.8. Expression of GlpK Enhances the Glycerol Metabolic Pathway {#sec2dot8-ijms-20-05737}
---------------------------------------------------------------

Glycerol is catabolized in the cells by GlpK to glycerol-3-phosphate and then oxidized to dihydroxyacetone-phosphate (DHAP) by glycerol-3-phosphate dehydrogenase (GlpD) before it is metabolized in the sugar-degrading pathway ([Figure 4](#ijms-20-05737-f004){ref-type="fig"}a). The genome of *C. necator* H16 \[[@B8-ijms-20-05737]\] contains two pairs of putative glycerol metabolism genes (GlpK and GlpD; [Figure S6](#app1-ijms-20-05737){ref-type="app"} and [Table S2](#app1-ijms-20-05737){ref-type="app"}). The first pair has the gene loci of H16_A2507 and H16_A2508 and the second pair H16_B1198 and H16_B1199. The GlpK encoded by H16_A2507 has the highest protein sequence identity (52%) to GlpK~Ec~, compared to the other three proteins that have 27% to 30% sequence identity ([Table S2](#app1-ijms-20-05737){ref-type="app"}). Previous work by Shimizu et al. showed that the first pair of genes had a slightly higher transcriptional level \[[@B32-ijms-20-05737]\].

Since expression of the four mutated genes in v6C6 suggested GlpK may play an important role in glycerol assimilation, the *glpK~H16~* and *glpD~H16~* from gene loci H16_A2507 and H16_A2508 in the wild-type strain were amplified and cloned using pBBR1-based plasmid for expression in *C. necator* H16 wild-type. All genes were cloned downstream of a constitutive promoter P*~j5~*~\[A1A3C2\]~ \[[@B10-ijms-20-05737]\] ([Figure 7](#ijms-20-05737-f007){ref-type="fig"}b) and individual effects of GlpK~H16~ and GlpD~H16~ expression and in combination (glpKD~H16~) were investigated. Constructs pP*~j5~*~\[A1A3C2\]~-glpKD~H16~-O1 and pP*~j5~*~\[A1A3C2\]~-glpKD~H16~-O2 differed in the ribosome binding site (rbs) preceding the *glpD~H16~* gene. While pP*~j5~*~\[A1A3C2\]~-glpKD~H16~-O1 used the native *glpD~H16~* rbs, pP*~j5~*~\[A1A3C2\]~-glpKD~H16~-O2 had the same synthetic rbs preceding both *glpK~H16~* and *glpD~H16~* genes. To compare the differences between GlpK from *C. necator* H16 (GlpK~H16~) and GlpK from *E. coli* (GlpK~Ec~), plasmid pP*~j5~*~\[A1A3C2\]~-glpK~Ec~ was also constructed ([Figure 7](#ijms-20-05737-f007){ref-type="fig"}b).

*Cupriavidus necator* H16 carrying plasmids pP*~j5~*~\[A1A3C2\]~-glpK~H16~, pP*~j5~*~\[A1A3C2\]~-glpKD~H16~-O1, or pP*~j5~*~\[A1A3C2\]~-glpKD~H16~-O2 had specific growth rates of 0.13--0.14 h^−1^ when cultivated in 0.50% (*w*/*v*) glycerol compared to 0.021 h^−1^ for the wild-type ([Table 1](#ijms-20-05737-t001){ref-type="table"}, [Figure 7](#ijms-20-05737-f007){ref-type="fig"}c). This suggests that glycerol kinase (GlpK~H16~) plays a more dominant role compared to GlpD~H16~ for improving growth in glycerol. Improved glycerol assimilation due to plasmid-based expression of GlpK~H16~ from the wild-type strain also suggested a positive effect of *glpK~H16~* gene dosage on glycerol assimilation. Interestingly, the strain harboring pP*~j5~*~\[A1A3C2\]~-glpD~H16~ plasmid could not grow in glycerol, even though the presence of plasmid-borne *glpD~H1~*~6~ gene in the transformed cells was confirmed by colony PCR. It is possible that increasing GlpD~H16~ expression leads to DHAP accumulation, which in turn gets converted into methylglyoxal via the action of methylglyoxal synthase (MgsA, encoded by H16_A0932). Methylglyoxal, being a highly reactive dicarbonyl compound, is one of the most potent glycating agents, readily reacting with proteins, lipids, and nucleic acids leading to cellular damage \[[@B33-ijms-20-05737]\]. The *C. necator* H16 transformed with pP*~j5~*~\[A1A3C2\]~-glpK~Ec~ showed a specific growth rate of 0.15 h^−1^ in glycerol, similar to the improvement achieved with pP*~j5~*~\[A1A3C2\]~-glpK~H16~ (0.14 h^−1^). Plasmid pP*~j5~*~\[A1A3C2\]~-glpK~H16~, when transformed into the v6C6 variant, had a specific growth rate of 0.21 h^−1^, similar to the growth rate of v6C6 on its own (0.20 h^−1^), thus no additive effect in growth improvement was observed.

3. Methods {#sec3-ijms-20-05737}
==========

3.1. Bacterial Strains, Plasmids, and Cultivation Conditions {#sec3dot1-ijms-20-05737}
------------------------------------------------------------

All bacterial strains and plasmids used in this study are listed in [Table 4](#ijms-20-05737-t004){ref-type="table"}. *Escherichia coli* strain DH5α, used for molecular cloning and plasmid propagation, was cultivated in 2 × YT medium (16 g/L tryptone, 10 g/L yeast extract, 5 g/L sodium chloride) at 37 °C and 250 rpm (ES-20 shaker-incubator; Grant Instruments, Shepreth, UK). *C. necator* H16 was cultivated in mineral salts medium (MSM, pH 7.0) \[[@B34-ijms-20-05737]\] or nutrient broth (5 g/L peptone, 1 g/L beef extract, 2 g/L yeast extract, 5 g/L sodium chloride) at 30 °C and 250 rpm (MaxQTM 4450 benchtop orbital shaker; Thermo Fisher Scientific, Loughborough, UK). Stock solution of glycerol was sterilized either by autoclave or using a 0.2 μm filter. When necessary, the medium was supplemented with 25 μg/mL chloramphenicol. Further, 10 μg/mL gentamicin was always added for the cultivation of *C. necator* H16 and its variants. Cell growth was monitored via optical density measurement at 600 nm (BioPhotometer Plus UV/Vis photometer; Eppendorf, Stevenage, UK) or at 595 nm (MultiskanTM FC microplate photometer; Thermo Fisher Scientific, Loughborough, UK). Specific growth rate was calculated by fitting the exponential growth to the exponential growth equation (Y = Y0 × e^kX^) provided in GraphPad Prism (GraphPad Software, La Jolla, CA, USA).

3.2. Adaptive Evolution of *C. necator* H16 for Enhanced Growth in Glycerol {#sec3dot2-ijms-20-05737}
---------------------------------------------------------------------------

Adaptive evolution of *C. necator* H16 was performed by serial passages in 5 mL of MSM supplemented with 0.50% (*w*/*v*) glycerol as sole carbon source. In each round, cells were grown to early stationary phase (OD~600~ 5−6) before 50 μL was used to inoculate the subsequent round. Serial passage was continued until there was no significant improvement in cell growth rate. A glycerol stock of the cell population in each round was prepared and stored at −80 °C. Cells from the fourth to sixth rounds were re-cultivated in MSM with 0.50% (*w*/*v*) glycerol to OD~600~ 1.0 before they were plated on MSM agar plate with the same glycerol concentration. Agar plates were incubated at 30 °C for 48 h before \~90 single colonies from each round were transferred to 96-well microtiter plates and re-screened in MSM with 0.50% (*w*/*v*) glycerol. The fastest growing variants were isolated for characterization.

3.3. Confirmation of Improved Glycerol-Utilizing Phenotype {#sec3dot3-ijms-20-05737}
----------------------------------------------------------

Improved glycerol-utilizing phenotype in the identified variants was verified by five rounds of cultivation, in either MSM with 1.00% (*w*/*v*) sodium gluconate or nutrient broth ([Figure S7](#app1-ijms-20-05737){ref-type="app"}). In each of these rounds, cells were cultivated for 48 h at 30°C. Cells from the fifth round were then used to inoculate MSM with 0.50% (*w*/*v*) glycerol. True variants were expected to grow as quickly as when they were first isolated, in contrast to those that exhibited transient adaptation.

3.4. Carbon Utilization of *C. necator* H16 Wild-Type and v6C6 in Gluconate--Glycerol Medium {#sec3dot4-ijms-20-05737}
--------------------------------------------------------------------------------------------

Pre-cultures of *C. necator* H16 wild-type and variant v6C6 were prepared from single colonies in MSM with 1.00% (*w*/*v*) sodium gluconate. Each pre-culture was used to inoculate 5 mL MSM with different carbon sources to a starting OD~600~ of 0.2. Three different media were investigated; MSM with 0.60% (*w*/*v*) sodium gluconate, MSM with 0.50% (*w*/*v*) glycerol, and MSM with 0.30% (*w*/*v*) sodium gluconate and 0.25% (*w*/*v*) glycerol. Culture (0.5 mL) was sampled at start of cultivation, log phase, and stationary phase of growth. Sample was centrifuged (21,000 g, 5 min) to separate the cells from the spent culture media. The spent media was clarified using a 0.2-μm spin column (10,000 g, 1 min) to remove any cell particles. Concentrations of sodium gluconate and glycerol in the culture media were determined by high-performance liquid chromatography (HPLC) using the Prominence-i LC-2030C Plus (Shimadzu UK Ltd., Milton Keynes, UK) equipped with a Rezex ROA-Organic Acid column (300 × 7.8 mm; Phenomenex, Macclesfield, UK) and a refractive index detector. Ten microliters of sample were injected using an autosampler and isocratic separation of sodium gluconate and glycerol was achieved at 60 °C using 0.005 N sulphuric acid flowing at 0.6 mL/min as the mobile phase. The concentrations of these compounds were estimated from standard curves generated by analyzing known concentrations of sodium gluconate and glycerol (both ≥  99% purity; Sigma-Aldrich, Dorset, UK). The standard error of the HPLC measurements was always between 1.0%--1.5%.

3.5. Growth of *C. necator* H16 Wild-Type and v6C6 in Different Carbon Sources {#sec3dot5-ijms-20-05737}
------------------------------------------------------------------------------

Pre-culture of *C. necator* H16 WT and v6C6 was cultivated from a single colony in 5 mL of nutrient broth at 30°C. Fifty microliters of pre-culture were used to inoculate MSM with five different carbon sources (1.0% (*w*/*v*) sodium gluconate, 1.0% (*w*/*v*) fructose, 1.0% (*w*/*v*) *N*-acetylglucosamine, 1.0% (*w*/*v*) glycerol, or 0.5% (*w*/*v*) each of gluconate and glycerol). Cell growth was monitored via optical density measurement at 600 nm. The experiment was performed in triplicate.

3.6. Analysis of PHB Content Using the Nile Red Assay {#sec3dot6-ijms-20-05737}
-----------------------------------------------------

*C. necator* H16 wild-type and its v6C6 variant were each cultivated in four different media; (i) MSM with 0.59% (*w*/*v*) gluconate and 0.10% (*w*/*v*) NH~4~Cl; (ii) MSM with 0.59% (*w*/*v*) gluconate and 0.05% (*w*/*v*) NH~4~Cl; (iii) MSM with 0.50% (*w*/*v*) glycerol and 0.10% (*w*/*v*) NH~4~Cl; and (iv) MSM with 0.50% (*w*/*v*) glycerol and 0.05% (*w*/*v*) NH~4~Cl. Half a milliliter of pre-culture was used to inoculate 50 mL of each medium. The cells were cultivated at 30 °C and 250 rpm, and the growth was monitored using optical density measurement. Cell samples were taken at the lag, exponential, early stationary, and late stationary phases for PHB quantification. When OD~600~ \> 2, the cell samples were diluted to OD~600~ ≤ 2 using MSM to keep the fluorescence detection within the linear range ([Figure S1](#app1-ijms-20-05737){ref-type="app"}). Subsequently, 1-mL aliquots of all cells were centrifuged and spent media was removed. Cell pellets were stored at −20 °C until all samples were collected. To compare PHB production using the Nile red assay, all cell pellets were thawed, and each was re-suspended in 0.5 mL of 50% (*v*/*v*) ethanol solution before 50 μL of cell suspension was mixed with 50 μL of 10 µg/mL Nile Red in a microtiter plate. The fluorescence was measured at an excitation wavelength of 552 nm and an emission wavelength of 600 nm using the SpectraMax M2e microplate reader (Molecular Devices, Winnersh, UK) for 1 h at 10 min intervals. Fluorescence values were stable at 1 h for all samples and comparisons between samples were made at this time point. The experiment was performed in triplicate. Comparison of PHB production was based on the fluorescence per 100 μL of cell culture.

3.7. Growth of *C. necator* H16 in Crude Glycerol (Sweetwater) {#sec3dot7-ijms-20-05737}
--------------------------------------------------------------

Crude glycerol (sweetwater) sample (batch 8/1/18; 10--15% *v*/*v* glycerol), obtained from a high-pressure fat-splitting process, was kindly provided by Croda (Hull, UK). A pre-culture was prepared from a single colony in MSM with 1.00% (*w*/*v*) gluconate. For growth comparison, 5 mL of MSM with 1.00%--4.00% (*v*/*v*) crude glycerol was inoculated to a starting OD~600~ of 0.1 using the pre-culture. Cells were cultivated at 30 °C and their optical density monitored.

3.8. Genome Sequencing {#sec3dot8-ijms-20-05737}
----------------------

The strains (wild-type, v6C6, v6F8, and v6G7) were streaked out on a nutrient broth agar plate with gentamicin and incubated at 30 °C for 40−48 h. A single colony was isolated and resuspended in 100 μL of sterile PBS buffer. The resuspended cells are then streaked out on a fresh nutrient broth agar plate with gentamicin again to create a bacteria lawn that covers about a third of the plate and cultivated at 30 °C for 40−48 h. A sterile loop was used to transfer all the bacteria from the plate into the barcoded bead tube provided by MicrobesNG (Birmingham, UK). Genomic DNA extraction, genome sequencing, genome assembly, and variant calling were performed by MicrobesNG.

3.9. Expression of GlpK and/or glpD Genes in *C. necator* H16--Plasmid Construction and Bacterial Cultivation {#sec3dot9-ijms-20-05737}
-------------------------------------------------------------------------------------------------------------

Total genomic DNA of *E. coli* BW25113, *C. necator* H16 wild-type, and *C. necator* H16 variant v6C6 were isolated using E.Z.N.A.^®^ Bacterial DNA Kit (Omega Bio-Tek, Norcross, GA, USA). Genes *A0689~v6C6~*, *A1373~v6C6~*, H16, *glpK~v6C6~*, and *A3075~v6C6~* were amplified from the v6C6 variant by PCR. Genes *glpK~H16~*, *glpD~H16~*, and *glpK~Ec~* were amplified from the wild-type strain of the respective genomic DNA by PCR. All DNA modifying enzymes were purchased from New England Biolabs Ltd. (Hitchin, UK) and used according to the manufacturer's instruction. All oligonucleotides were purchased from Eurofins Genomics (Ebersberg, Germany). The sequences of all primers used in this work are shown in [Table S3](#app1-ijms-20-05737){ref-type="app"}. Plasmid DNA was isolated using E.Z.N.A.^®^ Plasmid Mini Kit I (Omega Bio-Tek, Norcross, GA, USA). PCR and gel purifications were performed using NucleoSpin^®^ Gel and PCR Clean-up (Macherey-Nagel, Düren, Germany). All genes were cloned by replacing the rfp gene in pP*~j5~*~\[C2\]~-RFP \[[@B10-ijms-20-05737]\] with the target gene. Standard restrictive digestion and ligation were used for all plasmids except pP*~j5~*~\[A1A3C2\]~-glpKD~H16~-O2, which was constructed using the NEBuilder^®^ HiFi DNA Assembly Cloning Kit (New England Biolabs Ltd., Hitchin, UK). Plasmids were transformed into *E. coli* DH5α using the standard CaCl~2~ method. DNA sequencing showed mutations in the promoter region of pP*~j5~*~\[C2\]~-glpK~H16~. For this reason, all genes were subsequently re-cloned to have the same mutated promoter (P*~j5~*~\[A1A3C2\]~) for a fair comparison (see [Table S1](#app1-ijms-20-05737){ref-type="app"} for the sequence of P*~j5~*~\[A1A3C2\]~).

To determine their effects on growth in glycerol, plasmids were transformed into *C. necator* H16 by electroporation \[[@B36-ijms-20-05737]\]. A pre-culture was prepared from a single colony in MSM with 1.00% (*w*/*v*) gluconate. For growth comparison, 5 mL of MSM with 0.50% (*w*/*v*) glycerol was inoculated to a starting OD~600~ of 0.1 using the pre-culture unless otherwise stated. Cells were cultivated at 30 °C and their optical density monitored. The experiment was performed in triplicate. *C. necator* H16 wild-type or its v6C6 variant was always included for comparison.

4. Conclusions {#sec4-ijms-20-05737}
==============

This work unlocked the glycerol-utilizing ability of *C. necator* H16 through the use of adaptive evolution. The best variant, v6C6, has a specific growth rate that is 9.5 times faster than the wild-type, co-utilizes gluconate and glycerol, and produces more PHB in glycerol compared to its favorable carbon source of gluconate. Whole-genome sequencing of the wild-type and three variants identified four non-synonymous mutations in the genome and provided insights into the genetic changes that led to the improved glycerol-utilizing phenotype observed. Expression of the proteins encoded by these mutated genes in v6C6 suggested GlpK~H16~ has an important role in this improved glycerol assimilation. Further investigation through plasmid-based expression of the GlpK and GlpD in the glycerol metabolic pathway confirms the effect of GlpK expression for improving glycerol metabolism in *C. necator* H16. Importantly, the improved glycerol assimilation of v6C6 was also demonstrated for sweetwater, a glycerol-rich waste stream obtained from the industrial fat-splitting process. Improved glycerol utilization and the ability to co-utilize glycerol with other carbon sources in variant v6C6 presents the opportunity for economical polyhydroxyalkanoate production from industrial glycerol by-product and other carbon waste feedstock.
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![Growth curves of *C. necator* H16 wild-type in gluconate and laboratory-grade glycerol; 0.59% (*w*/*v*) sodium gluconate (blue line; circle), 0.50% (*w*/*v*) glycerol (red line; square), 1.00% (*w*/*v*) glycerol (green line; triangle), and 2.00% (*w*/*v*) glycerol (purple line; inverted triangle). The inset shows the magnified growth curve of *C. necator* H16 wild-type in 0.59% (*w/v*) sodium gluconate (blue line; circle) and 0.50% (*w/v*) glycerol (red line; square), with the dotted lines indicating OD~600~ of 1.0 and 5.0.](ijms-20-05737-g001){#ijms-20-05737-f001}

![(**a**) Growth curves of *C. necator* H16 in the six serial passages during adaptive evolution; Round 1 (red line; solid square), Round 2 (purple line; solid triangle), Round 3 (orange line; solid inverted triangle), Round 4 (grey line; open triangle), Round 5 (pink line; open inverted triangle), and Round 6 (green line; open square). (**b**) Growth curve of *C. necator* H16 wild-type in 0.59% (*w*/*v*) sodium gluconate (blue line; solid circle) and v6C6 variant in 0.50% (*w*/*v*) glycerol (green line; solid diamond), with the dotted lines indicating OD~600~ values of 1.0 and 5.0.](ijms-20-05737-g002){#ijms-20-05737-f002}

![(**a**) Growth curves of wild-type (black lines) and variant v6C6 (red line) in mineral salts medium (MSM) with 0.59% (*w*/*v*) sodium gluconate (circle), MSM with 0.50% (*w*/*v*) glycerol (square), and MSM with 0.30% (*w*/*v*) sodium gluconate and 0.25% (*w*/*v*) glycerol (triangle). (**b**,**c**) The growth curve (black line; triangle) and concentrations of sodium gluconate (green line, diamond) and glycerol (blue line; inverted triangle) in the culture media determined using HPLC for *C. necator* H16 wild-type (b) and v6C6 (c) cultivated in MSM with 0.30% (*w*/*v*) sodium gluconate and 0.25% (*w*/*v*) glycerol.](ijms-20-05737-g003){#ijms-20-05737-f003}

![Utilization of different carbon sources by wild-type and variant v6C6. (**a**) The metabolic pathway for *N*-acetylglucosamine, fructose, gluconate, and glycerol assimilation in *C. necator* H16 via the Entner--Doudoroff (ED) pathway. (**b--f**) The growth curves of wild-type (solid line) and v6C6 (dotted line) in MSM with five different carbon sources; 1.0% (*w*/*v*) of sodium gluconate (b), 1.0% (*w*/*v*) fructose (c), 1.0% (*w*/*v*) *N*-acetylglucosamine (d), 1.0% (*w*/*v*) glycerol (e), and 0.5% (*w*/*v*) sodium gluconate and 0.5% (*w*/*v*) glycerol (f).](ijms-20-05737-g004){#ijms-20-05737-f004}

![Polyhydroxybutyrate (PHB) production surveyed using the Nile red fluorescence assay for *C. necator* H16 (black solid bars) and v6C6 variant (blue solid bars) in 0.59% (*w*/*v*) gluconate and *C. necator* H16 (black stripe bars) and v6C6 variant (blue stripe bars) in 0.50% (*w*/*v*) glycerol. Cells were cultivated either in nutrient-balanced (**a**) or nitrogen-limiting (**b**) MSM.](ijms-20-05737-g005){#ijms-20-05737-f005}

![(**a**) Growth of *C. necator* H16 wild-type (red lines, solid symbols) and v6C6 variant (blue lines, open symbols) in 1% (*v*/*v*) (circle), 2% (*v*/*v*) (square), and 4% (*v*/*v*) (triangle) crude glycerol (sweetwater). (**b**) Growth of *C. necator* H16 wild-type (red lines, solid symbols) and v6C6 variant (blue lines, open symbols) in 0.5% (*w*/*v*) (circle), 1% (*w*/*v*) (square), and 2% (*w*/*v*) (triangle) laboratory-grade glycerol.](ijms-20-05737-g006){#ijms-20-05737-f006}

![(**a**) General plasmid construct used for cloning of mutated genes identified from genome sequencing. (**b**) Various promoter and gene combinations of *glpK* and *glpD* used in this work. (**c**) Growth curves of *C. necator* H16 harboring *glpK~H16~*, *glpKD~H16~*, and *glpK~Ec~* plasmids when cultivated in 0.50% (*w*/*v*) glycerol; no plasmid (red line; square), pP*~j5~*~\[A1A3C2\]~-glpK~H16~ (orange line; diamond), pP*~j5~*~\[A1A3C2\]~-glpKD~H16~-O1 (grey line; triangle), pP*~j5~*~\[A1A3C2\]~-glpKD~H16~-O2 (pink line, inverted triangle), and pP*~j5~*~\[A1A3C2\]~-glpK~Ec~ (blue line; circle).](ijms-20-05737-g007){#ijms-20-05737-f007}

ijms-20-05737-t001_Table 1

###### 

Specific growth rate of *C. necator* H16 and v6C6 variant in sodium gluconate and laboratory-grade glycerol.

  Strain   Plasmid                              Carbon Source                      Specific Growth Rate (h^−1^)
  -------- ------------------------------------ ---------------------------------- ------------------------------
  H16      n.a.                                 0.59% (*w*/*v*) sodium gluconate   (2.4 ± 0.2) × 10^−1^
  H16      n.a.                                 0.5% (*w*/*v*) glycerol            (2.1 ± 0.1) × 10^−2^
  H16      n.a.                                 1.0% (*w*/*v*) glycerol            (2.0 ± 0.2) × 10^−2^
  H16      n.a.                                 2.0% (*w*/*v*) glycerol            (2.6 ± 0.2) × 10^−2^
  v6C6     n.a.                                 0.5% (*w*/*v*) glycerol            (2.0 ± 0.1) × 10^−1^
  v6C6     n.a.                                 1.0% (*w*/*v*) glycerol            (1.8 ± 0.1) × 10^−1^
  H16      pP*~j5~*~\[A1A3C2\]~-glpK~v6C6~      1.0% (*w*/*v*) glycerol            (0.8 ± 0.0) × 10^−1^
  H16      pP*~j5~*~\[A1A3C2\]~-glpK~H16~       0.5% (*w*/*v*) glycerol            (1.4 ± 0.1) × 10^−1^
  H16      pP*~j5~*~\[A1A3C2\]~-glpD~H16~       0.5% (*w*/*v*) glycerol            \-
  H16      pP*~j5~*~\[A1A3C2\]~-glpKD~H16~-O1   0.5% (*w*/*v*) glycerol            (1.3 ± 0.0) × 10^−1^
  H16      pP*~j5~*~\[A1A3C2\]~-glpKD~H16~-O2   0.5% (*w*/*v*) glycerol            (1.4 ± 0.0) × 10^−1^
  H16      pP*~j5~*~\[A1A3C2\]~-glpK~Ec~        0.5% (*w*/*v*) glycerol            (1.5 ± 0.1) × 10^−1^
  v6C6     pP*~j5~*~\[A1A3C2\]~-glpK~H16~       0.5% (*w*/*v*) glycerol            (2.1 ± 0.1) × 10^−1^

ijms-20-05737-t002_Table 2

###### 

Specific growth rate of *C. necator* H16 and v6C6 variant in crude glycerol (sweetwater).

  Strain   Crude Glycerol (% (v/v))   Specific Growth Rate (h^−1^)
  -------- -------------------------- ------------------------------
  H16      1                          (2.3 ± 0.1) × 10^−2^
  H16      2                          (3.1 ± 0.2) × 10^−2^
  H16      4                          (4.8 ± 0.4) × 10^−2^
  v6C6     1                          (1.7 ± 0.5) × 10^−1^
  v6C6     2                          (2.2 ± 0.3) × 10^−1^
  v6C6     4                          (2.2 ± 0.1) × 10^−1^

ijms-20-05737-t003_Table 3

###### 

Mutations identified in variants v6C6, v6F8, and v6G7. Nucleotide changes were identified by comparison to the sequenced wild-type.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------
  Chromosome   Gene Position   Mutation            Amino Acid Substitution   Strains with Mutation   Locus Tag   Product or Function (Protein ID)
  ------------ --------------- ------------------- ------------------------- ----------------------- ----------- -------------------------------------------
  1            738,900         T→A                 M129K                     v6C6\                   H16_A0689   Ornithine cyclodeaminase (WP_010813066.1)
                                                                             v6F8\                               
                                                                             v6G7                                

  1            1,486,642       G→C                 S736R                     v6C6                    H16_A1373   Histidine kinase (WP_037024292.1)

  1            1,487,637       Deletion (2 bp)     n.a.                      v6F8\                   H16_A1373   Histidine kinase (WP_037024292.1)
                                                                             v6G7                                

  1            1,864,239       Insertion (42 bp)   n.a.                      v6F8\                   n.a.        n.a.
                                                                             v6G7                                

  1            2,723,382       G→C                 W480S                     v6C6\                   H16_A2507   Glycerol kinase (WP_011615701.1)
                                                                             v6F8\                               
                                                                             v6G7                                

  1            3,328,089       A→C                 N261K                     v6C6\                   H16_A3075   Dihydropyrimidinase (WP_041687507.1)
                                                                             v6F8\                               
                                                                             v6G7                                
  ----------------------------------------------------------------------------------------------------------------------------------------------------------

ijms-20-05737-t004_Table 4

###### 

Bacterial strains and plasmids used in this study.

  Bacterial Strains and Plasmids                Description                                                                                                           Reference or Source
  --------------------------------------------- --------------------------------------------------------------------------------------------------------------------- --------------------------
  **Bacterial Strains**                                                                                                                                               
  ***E. coli* DH5α**                            Standard cloning strain                                                                                               Lab collection
  ***E. coli* BW25113**                         Wild-type                                                                                                             \[[@B35-ijms-20-05737]\]
  ***C. necator* H16**                          Wild-type                                                                                                             DSM 428
  **v6C6**                                      Variant of *C. necator* H16 with improved glycerol utilization                                                        This study
  **Plasmids**                                                                                                                                                        
  **pBBR1c-RFP**                                Cam^R^, mob, pBBR1 Rep, pBBR1 oriV, *araC*, P*~BAD~*, *rfp*                                                           This study
  **p** **P*~j5~*~\[C2\]~-** **RFP**            Cam^R^, mob, pBBR1 Rep, pBBR1 oriV, P*~j5~*~\[C2\]~, *rfp*                                                            This study
  **pP*~j5~*~\[A1A3C2\]~** **-glpK~Ec~**        Cam^R^, mob, pBBR1 Rep, pBBR1 oriV, P*~j5~*~\[A1A3C2\]~, *glpK~Ec~*                                                   This study
  **pP*~j5~*~\[A1A3C2\]~** **-glpK~H16~**       Cam^R^, mob, pBBR1 Rep, pBBR1 oriV, P*~j5~*~\[A1A3C2\]~, *glpK~H16~*                                                  This study
  **pP*~j5~*~\[A1A3C2\]~** **-glpD~H16~**       Cam^R^, mob, pBBR1 Rep, pBBR1 oriV, P*~j5~*~\[A1A3C2\]~, *glpD~H16~*                                                  This study
  **pP*~j5~*~\[A1A3C2\]~** **-glpKD~H16~-O1**   Cam^R^, mob, pBBR1 Rep, pBBR1 oriV, P*~j5~*~\[A1A3C2\]~, *glpKD~H16~*, native *glpD~H16~* rbs preceding *glpD~H16~*   This study
  **pP*~j5~*~\[A1A3C2\]~** **-glpKD~H16~-O2**   Cam^R^, mob, pBBR1 Rep, pBBR1 oriV, P*~j5~*~\[A1A3C2\]~, *glpKD~H16~*, synthetic rbs preceding *glpD~H16~*            This study
